Diabetic Eye Disease

We run multiple other studies for different indiciations aside from macular degeneration. Click through the below tabs to find out more!

Currently Recruiting

  • This is a Phase 2 study to evaluate the efficacy and safety of oral VX01 compared with placebo tablets for treatment of non-proliferative diabetic retinopathy (NPDR).
  • Study Duration: 1 year

Upcoming

  • Phase 3 study to evaluate safety and efficacy of intravitreal OTX-TKI (Axitinib implant) in participants with non-proliferative diabetic retinopathy (NPDR).  
  • Study Duration: 2 years

The Cureos Clinical Research Network provides research trials, site management and medical writing.

CONTACT US